Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/209126
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dalakas, Marinos C. | - |
dc.contributor.author | Dalmau Obrador, Josep | - |
dc.date.accessioned | 2024-03-25T10:25:01Z | - |
dc.date.available | 2024-03-25T10:25:01Z | - |
dc.date.issued | 2023-06-20 | - |
dc.identifier.issn | 2332-7812 | - |
dc.identifier.uri | http://hdl.handle.net/2445/209126 | - |
dc.description.abstract | With the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA)vaccinations, we have been witnessing a new era in vaccinology because these vaccines do not contain viral proteins but mRNA or viral vectors that instruct the cells to make viralspecific protective antibodies. To effectively fight SARS-CoV-2 infection, however, these vaccines need to induce both humoral and cell-mediated immune responses, with antibodies that block viral replication and viral-specific T cells that kill viral-infected cells and generate antibodyproducing plasma cells and long-lived memory cells. | - |
dc.format.extent | 3 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | NLM (Medline) | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1212/NXI.0000000000200010 | - |
dc.relation.ispartof | Neurology-Neuroimmunology & Neuroinflammation, 2022, vol. 9, num. 4 | - |
dc.relation.uri | https://doi.org/10.1212/NXI.0000000000200010 | - |
dc.rights | cc by-nc-nd (c) Dalakas, Marinos C. et al, 2022 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.source | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) | - |
dc.subject.classification | COVID-19 | - |
dc.subject.classification | Vacunes | - |
dc.subject.other | COVID-19 | - |
dc.subject.other | Vaccines | - |
dc.title | Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2023-06-20T12:49:20Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.idimarina | 9330605 | - |
dc.identifier.pmid | 35728948 | - |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Comment Humoral and T-cell Immunities to SARS-CoV-2 Vaccines_Neurology.pdf | 77.21 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License